Trillium Therapeutics Inc (TRIL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 330 | 567 | 609 | 6 | 250 |
| Accounts receivable | -454 | 71 | 521 | -120 | -21 |
| Other Working Capital | -646 | 1,693 | 750 | -303 | 25 |
| Other Operating Activity | -12,415 | -8,747 | -4,212 | -912 | -2,109 |
| Operating Cash Flow | $-13,186 | $-6,416 | $-2,332 | $-1,329 | $-1,855 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -541 | -150 | -32 | 0 | 2 |
| Net Acquisitions | N/A | 0 | -609 | N/A | N/A |
| Sale Of Investment | 0 | N/A | 98 | N/A | N/A |
| Other Investing Activity | 0 | 454 | 0 | 0 | 20 |
| Investing Cash Flow | $-541 | $304 | $-543 | $0 | $21 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 12 | N/A | N/A |
| Debt Repayment | -50 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 52,985 | 832 | 31,960 | 0 | 1,647 |
| Other Financing Activity | 133 | -140 | 93 | 0 | 0 |
| Financing Cash Flow | $53,069 | $692 | $32,065 | $0 | $1,647 |
| Exchange Rate Effect | 4,332 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 18,855 | 27,959 | 1,291 | 2,711 | 2,828 |
| End Cash Position | 62,529 | 22,539 | 30,482 | 1,382 | 2,641 |
| Net Cash Flow | $39,342 | $-5,420 | $29,191 | $-1,329 | $-186 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,186 | -6,416 | -2,332 | -1,329 | -1,855 |
| Capital Expenditure | -541 | -150 | -32 | N/A | N/A |
| Free Cash Flow | -13,727 | -6,566 | -2,364 | -1,329 | -1,855 |